Cancer Costs: India will cap trade margins on non-scheduled cancer drugs at 30%; medical-device makers are seeking similar controls, while experts say any cuts must reach patients without disrupting supply or quality. Maternal Care: Uttar Pradesh is expanding single-dose iron injections for pregnant women after a five-district pilot, aiming to improve treatment access and address anemia-related risks. Treatment Advances: The FDA approved once-monthly olanzapine for adults with schizophrenia and Tecentriq with chemotherapy for stage III dMMR colon cancer. Separately, early data on investigational CAR T therapy prula-cel showed remission in some patients with lupus, but the Phase 1 results involve a small group and need further study. Industry Influence: A new analysis links pharmaceutical company payments to changes in physicians’ prescribing, adding to calls for stronger scrutiny of drug marketing. Healthcare Costs: California’s plan to fine hospitals that exceed spending targets faces industry opposition, with critics arguing the caps may not account for inflation, drug costs, and an aging population.